Location History:
- Wellesley, MA (US) (2011 - 2018)
- Princeton, MA (US) (2016 - 2018)
Company Filing History:
4 out of 167 
4 out of 822 
3 out of 6 
Years Active: 2011-2018
Title: The Innovative Contributions of Eve H Barlow
Introduction
Eve H Barlow is a prominent inventor based in Wellesley, MA, known for her significant contributions to the field of biotechnology. With a total of 8 patents to her name, she has made remarkable advancements in the development of antibodies that target nerve growth factor (NGF). Her work has implications for treating various disorders where NGF activity is detrimental.
Latest Patents
Among her latest patents are "Caninized anti-NGF antibodies and their use" and "Anti-NGF antibodies and their use." These patents encompass NGF binding proteins, specifically focusing on chimeric, CDR grafted, and canonized antibodies. The antibodies described in these patents are useful for detecting NGF and inhibiting its activity in mammals suffering from related disorders.
Career Highlights
Eve has worked with notable companies such as AbbVie Deutschland GmbH & Co. KG and AbbVie Inc. Her experience in these organizations has allowed her to contribute to groundbreaking research and development in the field of therapeutic antibodies.
Collaborations
Throughout her career, Eve has collaborated with esteemed colleagues, including Mary Leddy and Bernhard K. Mueller. These partnerships have further enhanced her research and innovation in the biotechnology sector.
Conclusion
Eve H Barlow's contributions to the field of biotechnology through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in medical treatments targeting NGF-related disorders.